Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer

The association between germline BRCA1 and BRCA2 pathogenic variants (mutations: gBRCAm) and ovarian cancer risk is well established. Germline testing alone cannot detect somatic BRCA1/2 pathogenic variants (sBRCAm), which is calculated based on the proportion of tumor BRCAm (tBRCAm) from tumor samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Oda, Katsutoshi, Aoki, Daisuke, Tsuda, Hitoshi, Nishihara, Hiroshi, Aoyama, Hisanori, Inomata, Hyoe, Shimada, Muneaki, Enomoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807512/
https://www.ncbi.nlm.nih.gov/pubmed/36254756
http://dx.doi.org/10.1111/cas.15518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807512/
https://www.ncbi.nlm.nih.gov/pubmed/36254756
http://dx.doi.org/10.1111/cas.15518

Ejemplares similares